Jakautuvan Orion Oyj:n osakkeiden noteeraus Helsingin Pörssissä päättyy 30.6.2006
| Source: Orion Oyj
Recommended Reading
-
ORION CORPORATION PRESS RELEASE 24 OCTOBER 2026 at 9.35 EEST Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk...
Read More -
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 20 OCTOBER 2026 at 20.20 EEST Inside information: Orion upgrades full-year outlook for 2026 Orion Corporation upgrades the...
Read More